Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

MDGL

+ Watchlist+ Portfolio

Madrigal Pharmaceuticals, Inc.

Regulated industryPhysical productsTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$421.99
52-Week Range
$353.54 – $615.00
Market Cap
$9.25B
P/E (TTM)
—
EPS (TTM)
-5.85
Dividend Yield
0.00%
Advanced Metrics
Price/Book
14.74
PEG Ratio
—
Return on Equity
-24.82%
Return on Assets
-6.82%
Gross Margin
90.96%
Operating Margin
-10.69%
Profit Margin
-10.89%
Current Ratio
3.05
Debt/Equity
0.56
Total Debt
$354.22M
Free Cash Flow
$-112.43M
Revenue Growth
50.10%
Earnings Growth
—
Enterprise Value
$8.64B

Market Snapshot

About

Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics for liver diseases, including non-alcoholic steatohepatitis (NASH/MASH) and related metabolic disorders.